Sign in

    Robert Eno

    Board
    Since October 21, 2024
    Age
    57 years
    Education
    Holds an MBA from the Stanford Graduate School of Business and a BA, with Honors and Distinction, from Stanford University.
    Tenure
    Joined BEAT as President on January 18, 2023 and was promoted to CEO on October 21, 2024.

    Also at Heartbeam Inc

    BV
    Branislav Vajdic
    President
    KP
    Kenneth Persen
    Chief System Deployment Officer
    TC
    Timothy Cruickshank
    Chief Financial Officer

    About

    Robert Eno is a seasoned executive, currently 57 years old , with over 30 years of experience in the medical technology industry. He has built his career through senior roles, contributing to innovative diagnostic and treatment solutions.

    Holds an MBA from the Stanford Graduate School of Business and a BA, with Honors and Distinction, from Stanford University. His academic background laid the foundation for his successful career in leadership and strategic marketing roles at companies such as Preview Medical and HeartFlow.

    He joined BEAT as President on 01-18-2023 and was promoted to CEO on 10-21-2024. Under his leadership, BEAT has made significant strides, including obtaining FDA clearance for its groundbreaking 3D ECG technology, which highlights the company's commitment to innovation and growth.

    Recognized for his strategic vision and proven track record in the medical technology sector, his tenure at BEAT reflects a balanced blend of operational expertise and forward-thinking leadership, driving both product development and commercial success.

    $BEAT Performance Under Robert Eno

    Past Roles

    OrganizationRoleDate RangeDetails
    HeartBeam (BEAT)PresidentJanuary 2023 - October 2024Advanced company strategy and led technology commercialization efforts
    Preview MedicalCEON/ALed diagnostic equipment company focused on real-time, in vivo tissue classification using machine learning and proprietary optical signals
    HeartFlowSenior Vice President of MarketingN/AOversaw marketing and product functions, including the launch of HeartFlow FFRCT
    OptiMedicaSenior Marketing and Sales LeadershipN/AHeld senior marketing and sales leadership roles
    NeoGuide SystemsSenior Marketing and Sales LeadershipN/AHeld senior marketing and sales leadership roles
    Avantec VascularSenior Marketing and Sales LeadershipN/AHeld senior marketing and sales leadership roles

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Annual Salary$378,000 N/AEffective January 1, 2024 as President
    Annual Fee (CEO Appointment)$400,000 Semi-monthly installments Effective October 17, 2024 as CEO

    Performance Compensation

    Data from  FY 2024

    No information available on performance compensation for 2024